OrthoPediatrics (KIDS) Expected to Announce Quarterly Earnings on Tuesday

OrthoPediatrics (NASDAQ:KIDS) is anticipated to announce its Q3 2025 results after the market closes on Tuesday, October 28th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $63.6270 million for the quarter. Individuals can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Tuesday, October 28, 2025 at 4:30 PM ET.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Monday, January 9th. The company reported ($0.15) earnings per share (EPS) for the quarter. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%.The business had revenue of $25.08 million for the quarter. On average, analysts expect OrthoPediatrics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

OrthoPediatrics Stock Performance

KIDS opened at $17.03 on Friday. OrthoPediatrics has a 12-month low of $15.28 and a 12-month high of $32.00. The company has a current ratio of 6.66, a quick ratio of 3.43 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $426.94 million, a PE ratio of -9.51 and a beta of 1.02. The firm has a 50 day moving average of $19.13 and a two-hundred day moving average of $20.59.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of OrthoPediatrics in a research report on Saturday. Stifel Nicolaus reduced their price target on shares of OrthoPediatrics from $32.00 to $20.00 and set a “buy” rating for the company in a research report on Friday, October 10th. Citigroup reissued an “outperform” rating on shares of OrthoPediatrics in a research report on Friday, October 10th. Wall Street Zen lowered shares of OrthoPediatrics from a “hold” rating to a “sell” rating in a research report on Saturday, October 11th. Finally, Piper Sandler cut their target price on shares of OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Seven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $26.29.

Insider Transactions at OrthoPediatrics

In related news, CFO Fred Hite purchased 5,076 shares of the business’s stock in a transaction that occurred on Thursday, August 21st. The stock was bought at an average price of $19.41 per share, with a total value of $98,525.16. Following the acquisition, the chief financial officer owned 213,065 shares in the company, valued at $4,135,591.65. The trade was a 2.44% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 32.70% of the company’s stock.

Institutional Investors Weigh In On OrthoPediatrics

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock worth $246,000 after acquiring an additional 645 shares in the last quarter. Jane Street Group LLC purchased a new stake in OrthoPediatrics in the 1st quarter worth $389,000. Invesco Ltd. increased its holdings in OrthoPediatrics by 22.5% in the 2nd quarter. Invesco Ltd. now owns 22,482 shares of the company’s stock worth $483,000 after acquiring an additional 4,133 shares in the last quarter. American Century Companies Inc. increased its holdings in OrthoPediatrics by 12.5% in the 2nd quarter. American Century Companies Inc. now owns 34,486 shares of the company’s stock worth $741,000 after acquiring an additional 3,828 shares in the last quarter. Finally, Sei Investments Co. increased its holdings in OrthoPediatrics by 27.1% in the 2nd quarter. Sei Investments Co. now owns 38,947 shares of the company’s stock worth $837,000 after acquiring an additional 8,312 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.